SpyGlass Pharma (SGP) vs vVARDIS (VVVV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SpyGlass Pharma is the larger company by market cap ($1.02 billion vs $770.9 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SGP | VVVV |
|---|---|---|
| Share price | $30.43 | $14.55 |
| Market cap | $1.02B | $770.91M |
| 1-day change | -1.14% | -3.00% |
| EPS (TTM) | $-2.70 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-39.87M | — |
| 52-week high | $39.92 | $16.95 |
| 52-week low | $17.06 | $14.00 |
| Distance from 52-week high | -23.77% | -14.16% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +53.37% | — |
| Average volume | 114.63K | 963.08K |
| Shares outstanding | 33.46M | 38.59M |
| Employees | 88 | 153 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About SpyGlass Pharma
SGP stock →SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.
Health Care · Medical/Dental Instruments · 88 employees
About vVARDIS
VVVV stock →vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.
Health Care · Medical/Dental Instruments · 153 employees
SGP vs VVVV FAQ
Which is bigger, SpyGlass Pharma or vVARDIS?
SpyGlass Pharma (SGP) is larger, with a market capitalization of $1.02B compared with $770.91M for vVARDIS (VVVV).
Are SpyGlass Pharma and vVARDIS in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.